Baird Medical Investment Holdings Limited
BDMD
$3.14
$0.051.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 81.94% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 81.94% | |||
| Cost of Revenue | 0.00% | 66.37% | |||
| Gross Profit | 0.00% | 84.17% | |||
| SG&A Expenses | 0.00% | 55.22% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 69.93% | |||
| Operating Income | 0.00% | 100.93% | |||
| Income Before Tax | 0.00% | 90.07% | |||
| Income Tax Expenses | 0.00% | 109.48% | |||
| Earnings from Continuing Operations | 0.00% | 87.95% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -122.77% | |||
| Net Income | 0.00% | 87.59% | |||
| EBIT | 0.00% | 100.93% | |||
| EBITDA | 0.00% | 89.58% | |||
| EPS Basic | 0.00% | 154.35% | |||
| Normalized Basic EPS | 0.00% | 157.09% | |||
| EPS Diluted | 0.00% | 154.35% | |||
| Normalized Diluted EPS | 0.00% | 155.51% | |||
| Average Basic Shares Outstanding | 0.00% | -26.23% | |||
| Average Diluted Shares Outstanding | 0.00% | -25.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||